Skip to content
AdminAug 3, 2020 10:59:00 AM< 1 min read

CRL Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test

CRL has received FDA Emergency Use Authorization (EUA) and is scaling up capacity for CRL Rapid Response™, a saliva-based COVID-19 RT-PCR test that can be self-collected at home, work or any other setting. The test, shown in CRL’s EUA studies to be more sensitive and accurate than the standard COVID-19 anterior nasal swab test, detects the presence of coronavirus in the saliva of the test taker. In addition, the test is more comfortable and easier to administer, is not “technique dependent” and virtually anyone can self-collect an adequate sample for testing, with test results available in 24–48 hours of receipt at CRL.

“People should not have to choose between comfort or convenience and accuracy. CRL Rapid Response™ offers convenient self testing with better sample collection, protection and transport, combined with superior testing methodology, which leads to more accurate results and, ultimately, better public health outcomes,” said Dr. Heather Fehling, CRL’s Chief Scientific Officer, Molecular Diagnostics.

Click here for the full press release.

Various news coverage, including interviews with CRL CEO Robert Thompson, is linked below: